Cover Image
市場調查報告書

癌症生物標記市場分析:類型 (乳癌,前列腺癌,大腸癌,子宮頸癌,肝癌症,肺癌),純粹分子 (jenetikku,表觀遺傳,METABOLIC INC.,蛋白質體學),各用途,市場區隔預測

Cancer Biomarker Market Analysis By Type (Breast, Prostate, Colorectal, Cervical, Liver, Lung Cancer), By Biomolecule (Genetic, Epigenetic, Metabolic, Proteomic), By Application, And Segment Forecasts, 2014 - 2025

出版商 Grand View Research, Inc. 商品編碼 515348
出版日期 內容資訊 英文 85 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
癌症生物標記市場分析:類型 (乳癌,前列腺癌,大腸癌,子宮頸癌,肝癌症,肺癌),純粹分子 (jenetikku,表觀遺傳,METABOLIC INC.,蛋白質體學),各用途,市場區隔預測 Cancer Biomarker Market Analysis By Type (Breast, Prostate, Colorectal, Cervical, Liver, Lung Cancer), By Biomolecule (Genetic, Epigenetic, Metabolic, Proteomic), By Application, And Segment Forecasts, 2014 - 2025
出版日期: 2017年05月29日 內容資訊: 英文 85 Pages
簡介

本報告提供全球癌症生物標記市場相關調查,彙整市場概要和各類型,純粹各分子,各用途,各地區預測與趨勢,及打入市場的主要企業簡介等資料。

第1章 調查方法與調查範圍

第2章 摘要整理

第3章 產業預測

  • 市場區隔及範圍
    • 推動市場的要素分析
    • 阻礙市場的要素
  • 滲透率與成長預測製圖
  • SWOT分析
  • 產業分析:波特分析

第4章 各類型預測

  • 各類型市場佔有率
  • 乳癌
  • 前列腺癌
  • 大腸癌
  • 子宮頸癌
  • 肝癌症
  • 肺癌
  • 其他

第5章 純粹各分子預測與趨勢分析

  • 趨勢分析
  • jenetikkubaiomaka—
  • 表觀遺傳生物標記
  • METABOLIC INC.生物標記
  • 蛋白質體學生物標記
  • 其他

第6章 各用途預測與趨勢分析

  • 趨勢分析
  • 藥物研發
  • 診斷
  • 個人化醫療
  • 其他

第7章 各地區預測

  • 各地區市場佔有率
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第8章 企業簡介

  • 策略架構
  • 市場進入分類
  • 企業簡介
    • Abbott Laboratories
    • 9F. Hoffmann-La Roche Ltd
    • Qiagen N.V
    • Affymetrix Inc
    • Illumina, Inc
    • Agilent Technologies
    • Merck & Co. Inc
    • Hologic, Inc.
    • Sino Biological Inc.
    • Thermo Fisher Scientific Inc.

圖表

目錄
Product Code: GVR-1-68038-862-6

The global cancer biomarkers market is expected to reach a value of USD 33.7 billion by 2025, based on a new report by Grand View Research, Inc. Growing initiatives for development of drugs targeting novel cancer biomarkers coupled with the introduction of technologically advanced companion diagnostic kits is estimated to provide the market with high growth potential. Increasing awareness about personalized medicines amongst patients is further anticipated to boost adoption of cancer biomarkers.

In addition, presence of favorable government initiatives for the development of novel cancer diagnostic techniques is a key factor for market growth. For instance, the National Cancer Institute (NCI) provides funding to more than 8 research areas pertaining to cancer biomarker development. Cancer Research UK, Lung Cancer Research Foundation, and National Institutes of Health are some of the organizations providing funding for biomarker research.

People with high alcohol consumption, tobacco usage, unhealthy food habits, and sedentary lifestyle are reported to be 80% more at risk of developing cancer as compared to other individuals. Infections such as Human papillomavirus (HPV), Epstein-Barr virus, Hepatitis B virus, and Helicobacter pylori are also been studied to be related in cancer development.

Further Key findings from the study suggest:

  • Breast cancer was the largest segment by revenue share in 2016 owing to high prevalence of this type of cancer
  • Lung cancer is estimated to be the fastest-growing type due to increasing research activities toward development of novel lung cancer biomarkers
  • Genetic biomarkers, being the highest used and easily detectable held the majority share of cancer biomarker market by biomolecule in 2016
  • However, epigenetic biomarkers are anticipated to witness lucrative growth due to increasing focus on finding the role of epigenetic modifications in cancer development
  • Cancer biomarkers are majorly used for diagnostic purpose owing to their high specificity
  • The personalized medicine segment is estimated to witness fastest CAGR of 15.0% over the forecast period
  • North America dominated in terms of revenue share in 2016 due to established R&D infrastructure and high acceptance of biomarker-based cancer testing in this region
  • Asia Pacific is anticipated to grow at a substantial growth rate till 2025 with CAGR of over 16.7%
  • Some of the major companies in the cancer biomarkers market are Abbott Laboratories; F.Hoffmann-La Roche Ltd.; QIAGEN; Thermo Fisher Scientific Inc.; Affymetrix Inc.; Illumina, Inc.; Agilent Technologies; Merck & Co. Inc.; Hologic, Inc.; Sino Biological Inc.; and Becton, Dickinson and Company

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Information Procurement
    • 1.1.1. Purchased database:
    • 1.1.2. GVR's internal database
  • 1.2. Research Methodology
  • 1.3. Geographic Scope & Assumptions
  • 1.4. Region-wise Market Calculation
    • 1.4.1. Region-wise market: Base estimates
    • 1.4.2. Global market: CAGR calculation
  • 1.5. Region-based Segment Share Calculation
  • 1.6. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot

Chapter 3. Cancer Biomarkers Industry Outlook

  • 3.1. Market Segmentation & Scope
    • 3.1.1. Market driver analysis
      • 3.1.1.1 Growing geriatric population base
      • 3.1.1.2 Growing prevalence of cancer
      • 3.1.1.3 Increasing government funding for cancer research
      • 3.1.1.4 Technological advancements
    • 3.1.2. Market restraint analysis
      • 3.1.2.1 Large capital investments and production cost
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Cancer biomarkers - SWOT Analysis, By Factor (political & legal, economic and technological)
  • 3.4. Industry Analysis - Porter's

Chapter 4. Cancer Biomarkers Market: Type Outlook

  • 4.1. Cancer biomarkers market share by type, movement analysis
  • 4.2. Breast cancer
    • 4.2.1. Breast cancer Market estimates and forecast, 2014 - 2025 (USD Billion)
  • 4.4. Prostate Cancer
    • 4.4.1. Prostate cancer market estimates and forecast, 2014 - 2025 (USD Billion)
  • 4.5. Colorectal Cancer
    • 4.5.1. Colorectal cancer market estimates and forecast, 2014 - 2025 (USD Billion)
  • 4.6. Cervical Cancer
    • 4.6.1. Cervical cancer market estimates and forecast, 2014 - 2025 (USD Billion)
  • 4.7. Liver Cancer
    • 4.7.1. Liver cancer market estimates and forecast, 2014 - 2025 (USD Billion)
  • 4.8. Lung Cancer
    • 4.8.1. Lung cancer market estimates and forecast, 2014 - 2025 (USD Billion)
  • 4.9. Others
    • 4.9.1. Others market estimates and forecast, 2014 - 2025 (USD Billion)

Chapter 5. Cancer biomarkers Market: Biomolecule Estimates & Trend Analysis

  • 5.1. Cancer Biomarkers Market: Biomolecule Movement Analysis
  • 5.2. Genetic Biomarkers
    • 5.2.1. Genetic biomarkers market estimates and forecast, 2014 - 2025 (USD Billion)
  • 5.3. Epigenetic Biomarkers
    • 5.3.1. Epigenetic biomarkers market estimates and forecast, 2014 - 2025 (USD Billion)
  • 5.4. Metabolic Biomarkers
    • 5.4.1. Metabolic biomarkers market estimates and forecast, 2014 - 2025 (USD Billion)
  • 5.5. Proteomic Biomarkers
    • 5.5.1. Proteomic biomarkers market estimates and forecast, 2014 - 2025 (USD Billion)
  • 5.6. Others
    • 5.6.1. Others market estimates and forecast, 2014 - 2025 (USD Billion)

Chapter 6. Cancer biomarkers Market: Application Estimates & Trend Analysis

  • 6.1. Cancer Biomarkers Market: Application Movement Analysis
  • 6.2. Drug Discovery
    • 6.2.1. Drug discovery market estimates and forecast, 2014 - 2025 (USD Billion)
  • 6.3. Diagnostics
    • 6.3.1. Diagnostics market estimates and forecast, 2014 - 2025 (USD Billion)
  • 6.4. Personalized Medicine
    • 6.4.1. Personalized medicine market estimates and forecast, 2014 - 2025 (USD Billion)
  • 6.5. Others
    • 6.5.1. Others market estimates and forecast, 2014 - 2025 (USD Billion)

Chapter 7. Cancer Biomarkers Market: Regional Outlook

  • 7.1. Cancer biomarkers market share by region, 2015 & 2025 (USD Billion)
  • 7.2. North America
    • 7.2.1. Market estimates and forecast, 2014 - 2025 (USD Billion)
      • 7.2.1.1. Market estimates and forecast by type, 2014 - 2025 (USD Billion)
      • 7.2.1.2. Product market estimates and forecast by biomolecule, 2014 - 2025 (USD Billion)
      • 7.2.1.3. Market estimates and forecast by application, 2014 - 2025 (USD Billion)
    • 7.2.2. U.S.
      • 7.2.2.1. Market estimates and forecast, 2014 - 2025 (USD Billion)
      • 7.2.2.2. Market estimates and forecast by type, 2014 - 2025 (USD Billion)
      • 7.2.2.3. Product market estimates and forecast by biomolecule, 2014 - 2025 (USD Billion)
      • 7.2.2.4. Market estimates and forecast by application, 2014 - 2025 (USD Billion)
    • 7.2.3. Canada
      • 7.2.3.1. Market estimates and forecast, 2014 - 2025 (USD Billion)
      • 7.2.3.2. Market estimates and forecast by type, 2014 - 2025 (USD Billion)
      • 7.2.3.3. Product market estimates and forecast by biomolecule, 2014 - 2025 (USD Billion)
      • 7.2.3.4. Market estimates and forecast by application, 2014 - 2025 (USD Billion)
  • 7.3. Europe
    • 7.3.1. Market estimates and forecast, 2014 - 2025 (USD Billion)
      • 7.3.1.1. Market estimates and forecast by type, 2014 - 2025 (USD Billion)
      • 7.3.1.2. Product market estimates and forecast by biomolecule, 2014 - 2025 (USD Billion)
      • 7.3.1.3. Market estimates and forecast by application, 2014 - 2025 (USD Billion)
    • 7.3.2. Germany
      • 7.3.2.1. Market estimates and forecast, 2014 - 2025 (USD Billion)
      • 7.3.2.2. Market estimates and forecast by type, 2014 - 2025 (USD Billion)
      • 7.3.2.3. Product market estimates and forecast by biomolecule, 2014 - 2025 (USD Billion)
      • 7.3.2.4. Market estimates and forecast by application, 2014 - 2025 (USD Billion)
    • 7.3.3. UK
      • 7.3.3.1. Market estimates and forecast, 2014 - 2025 (USD Billion)
      • 7.3.3.2. Market estimates and forecast by type, 2014 - 2025 (USD Billion)
      • 7.3.3.3. Product market estimates and forecast by biomolecule, 2014 - 2025 (USD Billion)
      • 7.3.3.4. Market estimates and forecast by application, 2014 - 2025 (USD Billion)
  • 7.4. Asia Pacific
    • 7.4.1. Market estimates and forecast, 2014 - 2025 (USD Billion)
      • 7.4.1.1. Market estimates and forecast by type, 2014 - 2025 (USD Billion)
      • 7.4.1.2. Product market estimates and forecast by biomolecule, 2014 - 2025 (USD Billion)
      • 7.4.1.3. Market estimates and forecast by application, 2014 - 2025 (USD Billion)
    • 7.4.2. China
      • 7.4.2.1. Market estimates and forecast, 2014 - 2025 (USD Billion)
      • 7.4.2.2. Market estimates and forecast by type, 2014 - 2025 (USD Billion)
      • 7.4.2.3. Product market estimates and forecast by biomolecule, 2014 - 2025 (USD Billion)
      • 7.4.2.4. Market estimates and forecast by application, 2014 - 2025 (USD Billion)
    • 7.4.3. India
      • 7.4.3.1. Market estimates and forecast, 2014 - 2025 (USD Billion)
      • 7.4.3.2. Market estimates and forecast by type, 2014 - 2025 (USD Billion)
      • 7.4.3.3. Product market estimates and forecast by biomolecule, 2014 - 2025 (USD Billion)
      • 7.4.3.4. Market estimates and forecast by application, 2014 - 2025 (USD Billion)
    • 7.4.4. Japan
      • 7.4.4.1. Market estimates and forecast, 2014 - 2025 (USD Billion)
      • 7.4.4.2. Market estimates and forecast by type, 2014 - 2025 (USD Billion)
      • 7.4.4.3. Product market estimates and forecast by biomolecule, 2014 - 2025 (USD Billion)
      • 7.4.4.4. Market estimates and forecast by application, 2014 - 2025 (USD Billion)
  • 7.5. Latin America
    • 7.5.1. Market estimates and forecast, 2014 - 2025 (USD Billion)
      • 7.5.1.1. Market estimates and forecast by type, 2014 - 2025 (USD Billion)
      • 7.5.1.2. Product market estimates and forecast by biomolecule, 2014 - 2025 (USD Billion)
      • 7.5.1.3. Market estimates and forecast by application, 2014 - 2025 (USD Billion)
    • 7.5.2. Brazil
      • 7.5.2.1. Market estimates and forecast, 2014 - 2025 (USD Billion)
      • 7.5.2.2. Market estimates and forecast by type, 2014 - 2025 (USD Billion)
      • 7.5.2.3. Product market estimates and forecast by biomolecule, 2014 - 2025 (USD Billion)
      • 7.5.2.4. Market estimates and forecast by application, 2014 - 2025 (USD Billion)
    • 7.5.3. Mexico
      • 7.5.3.1. Market estimates and forecast, 2014 - 2025 (USD Billion)
      • 7.5.3.2. Market estimates and forecast by type, 2014 - 2025 (USD Billion)
      • 7.5.3.3. Product market estimates and forecast by biomolecule, 2014 - 2025 (USD Billion)
      • 7.5.3.4. Market estimates and forecast by application, 2014 - 2025 (USD Billion)
  • 7.6. Middle East & Africa
    • 7.6.1. Market estimates and forecast, 2014 - 2025 (USD Billion)
      • 7.6.1.1. Market estimates and forecast by type, 2014 - 2025 (USD Billion)
      • 7.6.1.2. Product market estimates and forecast by biomolecule, 2014 - 2025 (USD Billion)
      • 7.6.1.3. Market estimates and forecast by application, 2014 - 2025 (USD Billion)
    • 7.6.2. South Africa
      • 7.6.2.1. Market estimates and forecast, 2014 - 2025 (USD Billion)
      • 7.6.2.2. Market estimates and forecast by type, 2014 - 2025 (USD Billion)
      • 7.6.2.3. Product market estimates and forecast by biomolecule, 2014 - 2025 (USD Billion)
      • 7.6.2.4. Market estimates and forecast by application, 2014 - 2025 (USD Billion)

Chapter 8. Company Profiles

  • 8.1. Strategy Framework
  • 8.2. Market Participation Categorization
  • 8.3. Company Profiles
    • 8.3.1. Abbott Laboratories
      • 8.3.1.1. Company overview
      • 8.3.1.2. Financial performance
      • 8.3.1.3. Product benchmarking
      • 8.3.1.4. Strategic initiatives
    • 8.3.2. 9F. Hoffmann-La Roche Ltd
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Product benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. Qiagen N.V
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Product benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. Affymetrix Inc
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Illumina, Inc
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Agilent Technologies
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial overview
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Merck & Co. Inc
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial overview
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Hologic, Inc.
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial overview
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Sino Biological Inc.
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial overview
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Thermo Fisher Scientific Inc.
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial overview
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Becton, Dickinson and Company
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial overview
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives

List of Tables

  • TABLE 1 Country share estimation
  • TABLE 2 North America cancer biomarkers market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
  • TABLE 3 North America cancer biomarkers market estimates and forecasts, by biomolecule, 2014 - 2025 (USD Billion)
  • TABLE 4 North America cancer biomarkers market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
  • TABLE 5 U.S. cancer biomarkers market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
  • TABLE 6 U.S. cancer biomarkers market estimates and forecasts, by biomolecule, 2014 - 2025 (USD Billion)
  • TABLE 7 U.S. cancer biomarkers market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
  • TABLE 8 Canada cancer biomarkers market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
  • TABLE 9 Canada cancer biomarkers market estimates and forecasts, by biomolecule, 2014 - 2025 (USD Billion)
  • TABLE 10 Canada cancer biomarkers market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
  • TABLE 11 Europe cancer biomarkers market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
  • TABLE 12 Europe cancer biomarkers market estimates and forecasts, by biomolecule, 2014 - 2025 (USD Billion)
  • TABLE 13 Europe cancer biomarkers market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
  • TABLE 14 UK cancer biomarkers market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
  • TABLE 15 UK cancer biomarkers market estimates and forecasts, by biomolecule, 2014 - 2025 (USD Billion)
  • TABLE 16 UK cancer biomarkers market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
  • TABLE 17 Germany cancer biomarkers market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
  • TABLE 18 Germany cancer biomarkers market estimates and forecasts, by biomolecule, 2014 - 2025 (USD Billion)
  • TABLE 19 Germany cancer biomarkers market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
  • TABLE 20 Asia Pacific cancer biomarkers market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
  • TABLE 21 Asia Pacific cancer biomarkers market estimates and forecasts, by biomolecule, 2014 - 2025 (USD Billion)
  • TABLE 22 Asia Pacific cancer biomarkers market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
  • TABLE 23 Japan cancer biomarkers market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
  • TABLE 24 Japan cancer biomarkers market estimates and forecasts, by biomolecule, 2014 - 2025 (USD Billion)
  • TABLE 25 Japan cancer biomarkers market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
  • TABLE 26 China cancer biomarkers market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
  • TABLE 27 China cancer biomarkers market estimates and forecasts, by biomolecule, 2014 - 2025 (USD Billion)
  • TABLE 28 China cancer biomarkers market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
  • TABLE 29 India cancer biomarkers market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
  • TABLE 30 India cancer biomarkers market estimates and forecasts, by biomolecule, 2014 - 2025 (USD Billion)
  • TABLE 31 India cancer biomarkers market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
  • TABLE 32 Latin America cancer biomarkers market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
  • TABLE 33 Latin America cancer biomarkers market estimates and forecasts, by biomolecule, 2014 - 2025 (USD Billion)
  • TABLE 34 Latin America cancer biomarkers market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
  • TABLE 35 Brazil cancer biomarkers market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
  • TABLE 36 Brazil cancer biomarkers market estimates and forecasts, by biomolecule, 2014 - 2025 (USD Billion)
  • TABLE 37 Brazil cancer biomarkers market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
  • TABLE 38 Mexico cancer biomarkers market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
  • TABLE 39 Mexico cancer biomarkers market estimates and forecasts, by biomolecule, 2014 - 2025 (USD Billion)
  • TABLE 40 Mexico cancer biomarkers market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
  • TABLE 41 MEA cancer biomarkers market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
  • TABLE 42 MEA cancer biomarkers market estimates and forecasts, by biomolecule, 2014 - 2025 (USD Billion)
  • TABLE 43 MEA cancer biomarkers market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
  • TABLE 44 South Africa cancer biomarkers market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
  • TABLE 45 South Africa cancer biomarkers market estimates and forecasts, by biomolecule, 2014 - 2025 (USD Billion)
  • TABLE 46 South Africa cancer biomarkers market estimates and forecasts, by application, 2014 - 2025 (USD Billion)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Value chain based sizing & forecasting
  • FIG. 4 QFD modeling for market share assessment
  • FIG. 5 Market summary
  • FIG. 6 Market trends &outlook
  • FIG. 7 Market segmentation & scope
  • FIG. 8 Market driver relevance analysis (Current & future impact)
  • FIG. 9 Global percentage of population, by age group, 2050 and 2000
  • FIG. 10 Market restraint relevance analysis (Current & future impact)
  • FIG. 11 Penetration & growth prospect mapping
  • FIG. 12 SWOT Analysis, By Factor (political & legal, economic and technological)
  • FIG. 13 Porter's Five Forces Analysis
  • FIG. 14 Cancer biomarkers market type outlook key takeaways
  • FIG. 15 Cancer biomarkers market: Type movement analysis
  • FIG. 16 Global breast cancer market, 2014 - 2025 (USD Billion)
  • FIG. 17 Global prostate cancer market, 2014 - 2025 (USD Billion)
  • FIG. 18 Global colorectal cancer market, 2014 - 2025 (USD Billion)
  • FIG. 19 Global cervical cancer market, 2014 - 2025 (USD Billion)
  • FIG. 20 Global liver cancer market, 2014 - 2025 (USD Billion)
  • FIG. 21 Global lung cancer market, 2014 - 2025 (USD Billion)
  • FIG. 22 Global other cancer market, 2014 - 2025 (USD Billion)
  • FIG. 23 Cancer biomarkers market biomolecule outlook key takeaways
  • FIG. 24 Cancer biomarkers market: Biomolecule movement analysis
  • FIG. 25 Global genetic biomarkers market, 2014 - 2025 (USD Billion)
  • FIG. 26 Global epigenetic biomarkers market, 2014 - 2025 (USD Billion)
  • FIG. 27 Global metabolic biomarkers market, 2014 - 2025 (USD Billion)
  • FIG. 28 Global proteomic biomarkers market, 2014 - 2025 (USD Billion)
  • FIG. 29 Global other biomarkers market, 2014 - 2025 (USD Billion)
  • FIG. 30 Cancer biomarkers market application outlook key takeaways
  • FIG. 31 Cancer biomarkers market: Application movement analysis
  • FIG. 32 Drug discovery market, 2014 - 2025 (USD Billion)
  • FIG. 33 Diagnostics market, 2014 - 2025 (USD Billion)
  • FIG. 34 Personalized medicine market, 2014 - 2025 (USD Billion)
  • FIG. 35 Others market, 2014 - 2025 (USD Billion)
  • FIG. 36 Regional market place: Key takeaways
  • FIG. 37 Regional outlook, 2015 & 2025
  • FIG. 38 North America Cancer biomarkers market, 2014 - 2025 (USD Billion)
  • FIG. 39 U.S. cancer biomarkers market, 2014 - 2025 (USD Billion)
  • FIG. 40 Canada cancer biomarkers market, 2014 - 2025 (USD Billion)
  • FIG. 41 Europe cancer biomarkers market, 2014 - 2025 (USD Billion)
  • FIG. 42 UK cancer biomarkers market, 2014 - 2025 (USD Billion)
  • FIG. 43 Germany cancer biomarkers market, 2014 - 2025 (USD Billion)
  • FIG. 44 Asia Pacific cancer biomarkers market, 2014 - 2025 (USD Billion)
  • FIG. 45 Japan cancer biomarkers market, 2014 - 2025 (USD Billion)
  • FIG. 46 China cancer biomarkers market, 2014 - 2025 (USD Billion)
  • FIG. 47 India cancer biomarkers market, 2014 - 2025 (USD Billion)
  • FIG. 48 Latin America cancer biomarkers market, 2014 - 2025 (USD Billion)
  • FIG. 49 Brazil cancer biomarkers market, 2014 - 2025 (USD Billion)
  • FIG. 50 Mexico cancer biomarkers market, 2014 - 2025 (USD Billion)
  • FIG. 51 MEA cancer biomarkers market, 2014 - 2025 (USD Billion)
  • FIG. 52 South Africa cancer biomarkers market, 2014 - 2025 (USD Billion)
  • FIG. 53 Strategy framework
  • FIG. 54 Participant categorization
Back to Top